Lizhen G. Xu
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Non-contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage: An Analysis from ANNEXa-I Trial.
Journal: Annals of neurology
Published: April 28, 2026
Asundexian for Secondary Stroke Prevention.
Journal: The New England journal of medicine
Published: April 15, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention.
Journal: European stroke journal
Published: September 12, 2025
Andexanet alfa for the reversal of the low-molecular-weight heparin enoxaparin.
Journal: Research and practice in thrombosis and haemostasis
Published: August 06, 2025
Hemorrhagic Infarction Does Not Worsen Functional Outcomes in Noncardioembolic Ischemic Stroke: Secondary Analysis From PACIFIC-STROKE.
Journal: Stroke
Published: April 08, 2025
Long COVID prevalence and risk factors in adults residing in middle- and high-income countries: secondary analysis of the multinational Anti-Coronavirus Therapies (ACT) trials.
Journal: BMJ global health
Published: August 09, 2024
Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: July 31, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
Journal: The New England journal of medicine
Published: May 15, 2024
The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis.
Journal: Circulation
Published: April 15, 2024
Last Updated: 09/26/2026